ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
profitability factor · long-only model fund

Foundry Gross Profitability Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FGPXHYPOTHETICAL MODEL
Since ’99
+1290%
Expense Ratio
0.29%
placeholder
Holdings
214
cap-weighted
Inception
Oct 2021
placeholder
Full Sharpe
0.61
Ann. Return (LS)
11.2%
Ann. Volatility
18.4%
Max Drawdown
-33.0%
Test Sharpe ’19–26
0.55
Test FF5 α (ann.)
5.1%
vs Fama-French 5
Test FF5 α t-stat
0.96
not significant
Monthly turnover
7%
of the long leg, per rebalance
Cumulative return (LS)
1290%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.76
what this fund holds
Long leg ann. return
12.6%
buyable, long-only
Long-short Sharpe
0.61
requires shorting
Bottom bucket ann. return
1.3%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

214 of 214 · 100.0% of book
TickerCompanySectorMarket capWeight
1NVDA
NVIDIA CORPTechnology$4.91T
59.87%
2WMT
WALMART INCConsumer Defensive$909.13B
11.09%
3MA
MASTERCARD INCFinancial Services$480.32B
5.86%
4APP
APPLOVIN CORPTechnology$142.62B
1.74%
5BKNG
BOOKING HOLDINGS INCIndustrials$140.78B
1.72%
6SBUX
STARBUCKS CORPConsumer Cyclical$120.23B
1.47%
7ADBE
ADOBE INCTechnology$94.31B
1.15%
8CL
COLGATE PALMOLIVE COConsumer Defensive$74.40B
0.91%
9GWW
WW GRAINGER INCIndustrials$65.86B
0.80%
10FAST
FASTENAL COIndustrials$52.20B
0.64%
11ODFL
OLD DOMINION FREIGHT LINE INCIndustrials$48.63B
0.59%
12IDXX
IDEXX LABORATORIES INCHealthcare$44.76B
0.55%
13NTRA
NATERA INCHealthcare$38.87B
0.47%
14KR
KROGER COConsumer Defensive$36.04B
0.44%
15ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
0.44%
16RDDT
REDDIT INCCommunication Services$34.88B
0.43%
17UI
UBIQUITI INCTechnology$33.04B
0.40%
18FICO
FAIR ISAAC CORPTechnology$29.15B
0.36%
19TPR
TAPESTRY INCConsumer Cyclical$28.58B
0.35%
20JBHT
HUNT J B TRANSPORT SERVICES INCIndustrials$27.48B
0.34%
21WSM
WILLIAMS SONOMA INCConsumer Cyclical$26.89B
0.33%
22MTD
METTLER TOLEDO INTERNATIONAL INCHealthcare$26.47B
0.32%
23VRSN
VERISIGN INCTechnology$25.27B
0.31%
24XPO
XPO INCIndustrials$25.25B
0.31%
25EXPD
EXPEDITORS INTERNATIONAL OF WASHINGTON INCIndustrials$23.91B
0.29%
26TEAM
ATLASSIAN CORPTechnology$23.67B
0.29%
27LUV
SOUTHWEST AIRLINES COIndustrials$23.50B
0.29%
28INCY
INCYTE CORPHealthcare$23.42B
0.29%
29RL
RALPH LAUREN CORPConsumer Cyclical$22.64B
0.28%
30SN
SHARKNINJA INCConsumer Cyclical$21.87B
0.27%
31ROL
ROLLINS INCConsumer Cyclical$21.72B
0.26%
32ULTA
ULTA BEAUTY INCConsumer Cyclical$20.62B
0.25%
33BBY
BEST BUY CO INCConsumer Cyclical$18.00B
0.22%
34NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.21%
35THC
TENET HEALTHCARE CORPHealthcare$16.79B
0.20%
36NTNX
NUTANIX INCTechnology$14.89B
0.18%
37DECK
DECKERS OUTDOOR CORPConsumer Cyclical$14.79B
0.18%
38EXEL
EXELIXIS INCHealthcare$14.06B
0.17%
39PINS
PINTEREST INCCommunication Services$13.00B
0.16%
40MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.16%
41LULU
LULULEMON ATHLETICA INCConsumer Cyclical$12.61B
0.15%
42COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
0.15%
43AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.14%
44W
WAYFAIR INCConsumer Cyclical$11.79B
0.14%
45SAIA
SAIA INCIndustrials$11.65B
0.14%
46HUBS
HUBSPOT INCTechnology$11.49B
0.14%
47PODD
INSULET CORPHealthcare$11.36B
0.14%
48CART
INSTACART (MAPLEBEAR INC)Consumer Cyclical$10.77B
0.13%
49DPZ
DOMINOS PIZZA INCConsumer Cyclical$10.72B
0.13%
50DOCU
DOCUSIGN INCTechnology$10.07B
0.12%
51CORT
CORCEPT THERAPEUTICS INCHealthcare$9.72B
0.12%
52MANH
MANHATTAN ASSOCIATES INCTechnology$9.66B
0.12%
53LEVI
LEVI STRAUSS & COConsumer Cyclical$9.38B
0.11%
54DDS
DILLARD'S INCConsumer Cyclical$8.61B
0.10%
55CHWY
CHEWY INCConsumer Cyclical$8.57B
0.10%
56ETSY
ETSY INCConsumer Cyclical$7.98B
0.10%
57HIMS
HIMS & HERS HEALTH INCConsumer Defensive$7.60B
0.09%
58RSI
RUSH STREET INTERACTIVE INCConsumer Cyclical$7.56B
0.09%
59ACI
ALBERTSONS COMPANIES INCConsumer Defensive$7.47B
0.09%
60DBX
DROPBOX INCTechnology$7.14B
0.09%
61SFM
SPROUTS FARMERS MARKET INCConsumer Defensive$7.13B
0.09%
62LQDA
LIQUIDIA CORPHealthcare$7.11B
0.09%
63MSM
MSC INDUSTRIAL DIRECT CO INCIndustrials$6.97B
0.08%
64HNGE
HINGE HEALTH INCHealthcare$6.74B
0.08%
65APPF
APPFOLIO INCTechnology$6.36B
0.08%
66SEZL
SEZZLE INCFinancial Services$5.87B
0.07%
67PEGA
PEGASYSTEMS INCTechnology$5.39B
0.07%
68KVYO
KLAVIYO INCTechnology$5.29B
0.06%
69TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.06%
70RELY
REMITLY GLOBAL INCTechnology$5.08B
0.06%
71PTRN
PATTERN GROUP INCConsumer Cyclical$4.97B
0.06%
72KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.06%
73ACAD
ACADIA PHARMACEUTICALS INCHealthcare$4.38B
0.05%
74RHI
ROBERT HALF INCIndustrials$4.28B
0.05%
75ANF
ABERCROMBIE & FITCH COConsumer Cyclical$4.23B
0.05%
76BOX
BOX INCTechnology$4.22B
0.05%
77BBWI
BATH & BODY WORKS INCConsumer Cyclical$4.21B
0.05%
78KFY
KORN FERRYIndustrials$4.00B
0.05%
79EXTR
EXTREME NETWORKS INCTechnology$3.97B
0.05%
80IPAR
INTERPARFUMS INCConsumer Defensive$3.95B
0.05%
81WING
WINGSTOP INCConsumer Cyclical$3.88B
0.05%
82YETI
YETI HOLDINGS INCConsumer Cyclical$3.87B
0.05%
83LOPE
GRAND CANYON EDUCATION INCConsumer Defensive$3.72B
0.05%
84NHC
NATIONAL HEALTHCARE CORPHealthcare$3.56B
0.04%
85ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.04%
86RNG
RINGCENTRAL INCTechnology$3.46B
0.04%
87WDFC
WD 40 COBasic Materials$3.31B
0.04%
88COLM
COLUMBIA SPORTSWEAR COConsumer Cyclical$3.25B
0.04%
89WRBY
WARBY PARKER INCHealthcare$3.24B
0.04%
90CARG
CARGURUS INCConsumer Cyclical$3.16B
0.04%
91GRND
GRINDR INCTechnology$2.71B
0.03%
92TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.03%
93GRDN
GUARDIAN PHARMACY SERVICES INCHealthcare$2.57B
0.03%
94PTON
PELOTON INTERACTIVE INCConsumer Cyclical$2.55B
0.03%
95CALX
CALIX INCTechnology$2.50B
0.03%
96CMPR
CIMPRESS PLCCommunication Services$2.49B
0.03%
97BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.03%
98BKE
BUCKLE INCConsumer Cyclical$2.19B
0.03%
99AXGN
AXOGEN INCHealthcare$2.12B
0.03%
100CDNA
CAREDX INCHealthcare$2.05B
0.03%
101WMK
WEIS MARKETS INCConsumer Defensive$1.93B
0.02%
102APPN
APPIAN CORPTechnology$1.92B
0.02%
103CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.02%
104SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.02%
105NVCR
NOVOCURE LTDHealthcare$1.84B
0.02%
106SONO
SONOS INCTechnology$1.80B
0.02%
107FLO
FLOWERS FOODS INCConsumer Defensive$1.80B
0.02%
108RVLV
REVOLVE GROUP INCConsumer Cyclical$1.78B
0.02%
109ASAN
ASANA INCTechnology$1.77B
0.02%
110ATRC
ATRICURE INCHealthcare$1.77B
0.02%
111FIGS
FIGS INCConsumer Cyclical$1.72B
0.02%
112TDOC
TELADOC HEALTH INCHealthcare$1.70B
0.02%
113TRIP
TRIPADVISOR INCIndustrials$1.70B
0.02%
114ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.02%
115IDT
IDT CORPCommunication Services$1.57B
0.02%
116XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.02%
117INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.02%
118ARLO
ARLO TECHNOLOGIES INCBasic Materials$1.45B
0.02%
119YELP
YELP INCCommunication Services$1.44B
0.02%
120SBH
SALLY BEAUTY HOLDINGS INCConsumer Cyclical$1.42B
0.02%
121BJRI
BJS RESTAURANTS INCConsumer Cyclical$1.42B
0.02%
122BRBR
BELLRING BRANDS INCConsumer Defensive$1.41B
0.02%
123OMDA
OMADA HEALTH INCHealthcare$1.41B
0.02%
124WINA
WINMARK CORPConsumer Cyclical$1.39B
0.02%
125LINC
LINCOLN EDUCATIONAL SERVICES CORPConsumer Defensive$1.36B
0.02%
126REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.02%
127LZ
LEGALZOOMCOM INCIndustrials$1.33B
0.02%
128GIC
GLOBAL INDUSTRIAL COIndustrials$1.32B
0.02%
129ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.02%
130UPBD
UPBOUND GROUP INCTechnology$1.29B
0.02%
131ARDX
ARDELYX INCHealthcare$1.28B
0.02%
132AMPL
AMPLITUDE INCTechnology$1.27B
0.02%
133HLF
HERBALIFE LTDConsumer Defensive$1.24B
0.02%
134CBRL
CRACKER BARREL OLD COUNTRY STORE INCConsumer Cyclical$1.20B
0.01%
135PXED
PHOENIX EDUCATION PARTNERS INCConsumer Defensive$1.09B
0.01%
136GRPN
GROUPON INCCommunication Services$1.06B
0.01%
137KFRC
KFORCE INCIndustrials$1.04B
0.01%
138APEI
AMERICAN PUBLIC EDUCATION INCConsumer Defensive$930M
0.01%
139EVER
EVERQUOTE INCCommunication Services$925M
0.01%
140RDVT
RED VIOLET INCTechnology$920M
0.01%
141TALK
TALKSPACE INCHealthcare$873M
0.01%
142TDUP
THREDUP INCConsumer Cyclical$852M
0.01%
143SIBN
SI-BONE INCHealthcare$771M
0.01%
144KRT
KARAT PACKAGING INCConsumer Cyclical$760M
0.01%
145DSP
VIANT TECHNOLOGY INCTechnology$754M
0.01%
146MNTN
MNTN INCTechnology$661M
0.01%
147VLGEA
VILLAGE SUPER MARKET INCConsumer Defensive$659M
0.01%
148TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.01%
149NRDS
NERDWALLET INCCommunication Services$609M
0.01%
150OXM
OXFORD INDUSTRIES INCConsumer Cyclical$604M
0.01%
151GYRE
GYRE THERAPEUTICS INCHealthcare$587M
0.01%
152MYGN
MYRIAD GENETICS INCHealthcare$584M
0.01%
153WEAV
WEAVE COMMUNICATIONS INCHealthcare$575M
0.01%
154OOMA
OOMA INCCommunication Services$568M
0.01%
155ANGO
ANGIODYNAMICS INCHealthcare$558M
0.01%
156NPCE
NEUROPACE INCHealthcare$548M
0.01%
157YEXT
YEXT INCTechnology$535M
0.01%
158CTRN
CITI TRENDS INCConsumer Cyclical$535M
0.01%
159SPT
SPROUT SOCIAL INCTechnology$518M
0.01%
160NRC
NRC HEALTHHealthcare$491M
0.01%
161IBEX
IBEX LTDTechnology$474M
0.01%
162OFIX
ORTHOFIX MEDICAL INCHealthcare$468M
0.01%
163VMD
VIEMED HEALTHCARE INCHealthcare$466M
0.01%
164DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.01%
165PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.01%
166BBW
BUILD-A-BEAR WORKSHOP INCConsumer Cyclical$428M
0.01%
167QMCO
QUANTUM CORPTechnology$419M
0.01%
168HVT
HAVERTY FURNITURE COMPANIES INCConsumer Cyclical$413M
0.01%
169GCO
GENESCO INCConsumer Cyclical$411M
0.01%
170USNA
USANA HEALTH SCIENCES INCConsumer Defensive$403M
0.00%
171NATH
NATHANS FAMOUS INCConsumer Cyclical$393M
0.00%
172EOLS
EVOLUS INCHealthcare$377M
0.00%
173BBBY
BED BATH & BEYOND INCConsumer Cyclical$372M
0.00%
174FENC
FENNEC PHARMACEUTICALS INCHealthcare$365M
0.00%
175NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
176LE
LANDS' END INCConsumer Cyclical$357M
0.00%
177ELMD
ELECTROMED INCHealthcare$349M
0.00%
178XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.00%
179BKKT
BAKKT INCTechnology$323M
0.00%
180MKTW
MARKETWISE INCTechnology$314M
0.00%
181BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.00%
182DBI
DESIGNER BRANDS INCConsumer Cyclical$290M
0.00%
183SGHT
SIGHT SCIENCES INCHealthcare$274M
0.00%
184LOVE
LOVESAC COConsumer Cyclical$267M
0.00%
185QTTB
Q32 BIO INCHealthcare$255M
0.00%
186NUS
NU SKIN ENTERPRISES INCConsumer Defensive$254M
0.00%
187JILL
JJILL INCConsumer Cyclical$248M
0.00%
188SMTI
SANARA MEDTECH INCHealthcare$229M
0.00%
189FC
FRANKLIN COVEY COIndustrials$229M
0.00%
190KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
191AGEN
AGENUS INCHealthcare$209M
0.00%
192BDSX
BIODESIX INCHealthcare$204M
0.00%
193RCMT
RCM TECHNOLOGIES INCIndustrials$196M
0.00%
194INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
195MRDN
MERIDIAN HOLDINGS INCCommunication Services$171M
0.00%
196OWLT
OWLET INCHealthcare$162M
0.00%
197RCEL
AVITA MEDICAL INCHealthcare$157M
0.00%
198CUE
CUE BIOPHARMA INCHealthcare$126M
0.00%
199INSG
INSEEGO CORPTechnology$122M
0.00%
200AKA
AKA BRANDS HOLDING CORPConsumer Cyclical$119M
0.00%
201MED
MEDIFAST INCConsumer Cyclical$114M
0.00%
202TZOO
TRAVELZOOCommunication Services$113M
0.00%
203VRCA
VERRICA PHARMACEUTICALS INCHealthcare$96M
0.00%
204CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
205VNCE
VINCE HOLDING CORPConsumer Cyclical$83M
0.00%
206AEYE
AUDIOEYE INCTechnology$82M
0.00%
207BARK
BARK INCConsumer Cyclical$82M
0.00%
208LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
209ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
210BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
211BGSF
BGSF INCIndustrials$65M
0.00%
212WFCF
WHERE FOOD COMES FROM INCTechnology$63M
0.00%
213SNWV
SANUWAVE HEALTH INCHealthcare$55M
0.00%
214ACFN
ACORN ENERGY INCTechnology$51M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $8.20T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

8 sectors
Technology
65.4%
Consumer Defensive
13.1%
Financial Services
5.9%
Industrials
5.4%
Consumer Cyclical
5.3%
Healthcare
4.1%
Communication Services
0.7%
Basic Materials
0.1%

Portfolio Style

Size × value map of the long-leg book

214 classified
Value
Blend
Growth
Large
Mid
Small
2%4
11%19
85%42
<1%11
1%23
1%34
<1%20
<1%26
<1%16

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 92% toward Growth. +1% unclassified (19 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt99% → Large
SmallLarge
Value ↔ growth tilt92% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 214 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    38.2%
    Margin
    -36.8%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    59.9%
    Margin
    -34.9%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    60.3%
    Margin
    -35.3%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied
  • At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.

    Required
    >= 50.0%
    Actual
    38.2%
    Margin
    -11.8%

    Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 214 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.0 (95% CI 0.8-1.2)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
10.0%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.04x
within
parametric
1.02x
within
cornish fisher
0.95x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2013
Before publication (pre-2013)
0.54
Sharpe · 10.5% p.a.
January 1999December 2013 · 180 mo
Since publication
0.70
Sharpe · 12.1% p.a.
January 2014July 2026 · 151 mo
Change in Sharpe+0.15Sharpe strengthened since publication16% stronger in annual return

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
88%
23 of 26 3-year windows made money
Worst window
-1.09
Sharpe, January 2005 – December 2007
January 1999July 2026
Median Sharpe
0.65
Dispersion
0.61
Best window
1.81

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.11.9%-13.6%
3 yearsp.a.29.3%15.5%
5 yearsp.a.14.0%11.2%
10 yearsp.a.16.8%12.3%
Since inceptionp.a.11.8%10.0%
Calendar years
YearLong legLong-short
20267 mo4.5%-6.2%
202523.8%-2.7%
202460.2%59.6%
202320.8%-3.7%
2022-27.1%9.3%
202118.0%28.5%
202040.2%-2.1%
201930.9%6.3%
2018-0.4%38.7%
201722.5%16.1%
20161.7%-5.2%
20154.7%13.0%
201415.2%7.6%
201336.9%5.3%
201210.8%-0.1%
201111.5%5.4%
201020.6%2.1%
200937.2%10.5%
2008-33.9%12.5%
2007-5.5%-17.0%
20067.2%-8.4%
20053.0%-2.4%
200421.3%5.5%
200336.7%5.5%
2002-13.1%57.0%
2001-17.6%34.2%
200020.6%88.4%
199932.5%-20.7%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FGPX
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2021-10-14 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$8.20T

Methodology

The Foundry Gross Profitability Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Gross Profitability signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.